Nykode Therapeutics AS (CHIX:NYKDO) Preferred Dividends: kr0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:NYKDO Nykode Therapeutics AS CHIX:NYKDO
46 GF Score
Price kr18.69
GF Value kr30.52
! 2 Warning Signs
View Full Analysis

What is Nykode Therapeutics AS Preferred Dividends?

Nykode Therapeutics AS CHIX:NYKDO 46 Preferred Dividends is kr0.00 Mil as of Jun. 2026. GuruFocus rates CHIX:NYKDO with a GF Score™ of 46/100 and a GF Value™ of kr30.52. The stock has 2 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Nykode Therapeutics AS's preferred dividends for the three months ended in Jun. 2026 was kr0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.00 Mil.

Nykode Therapeutics AS  (CHIX:NYKDo) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nykode Therapeutics AS Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Nykode Therapeutics AS's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nykode Therapeutics AS Preferred Dividends Chart

Nykode Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nykode Therapeutics AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:NYKDO
46GF Score
Nykode Therapeutics AS CHIX:NYKDO
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nykode Therapeutics AS Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of kr0.00 Mil mean?
Nykode Therapeutics AS (CHIX:NYKDO) has a Preferred Dividends of kr0.00 Mil as of Jun. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Nykode Therapeutics AS and its competitors.
Is Nykode Therapeutics AS's Preferred Dividends too high?
Nykode Therapeutics AS's current Preferred Dividends is kr0.00 Mil. Overall, Nykode Therapeutics AS has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Nykode Therapeutics AS's Preferred Dividends compare to VRTX and REGN?
Nykode Therapeutics AS's Preferred Dividends of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Biotechnology company?
A good Preferred Dividends depends on the Biotechnology industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Nykode Therapeutics AS and its competitors. Nykode Therapeutics AS's current Preferred Dividends is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nykode Therapeutics AS stock overvalued right now?
Nykode Therapeutics AS (CHIX:NYKDO) has a current Preferred Dividends of kr0.00 Mil. The stock's GF Value™ is kr30.52, compared to a current price of kr18.69 — trading 38.8% below its estimated fair value. The current Preferred Dividends is kr0.00 Mil. Nykode Therapeutics AS's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Nykode Therapeutics AS (CHIX:NYKDO), the current Preferred Dividends is kr0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nykode Therapeutics AS (CHIX:NYKDO) Overvalued in 2026?

Based on GuruFocus' analysis, Nykode Therapeutics AS stock appears to be undervalued. The current stock price of kr18.69 is trading 38.8% below its estimated GF Value™ of kr30.52.

Key valuation signals for CHIX:NYKDO:

  • Preferred Dividends: kr0.00 Mil
  • GF Value™: kr30.52 vs. price of kr18.69 (38.8% below fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the CHIX:NYKDO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nykode Therapeutics AS Business Description

Address Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need using it's modular immunotherapy technology, specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid and long-lasting immune responses. It operates in United States of America.
46GF Score

Get the complete analysis for CHIX:NYKDO

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr18.69
Price
kr30.52
GF Value